Jasmine Rowe

Jasmine Rowe is a Director in Oral Formulation Sciences at Merck, where she is responsible for drug product development for the advancement of Merck’s oral small-molecule pipeline. Within her role, she is also leading systemic efforts to advance pediatric formulation development and amorphous solid dispersion technology development. Prior to Merck, she supported drug product development at Bristol Myers Squibb for ~10 years, holding roles in Oral Drug Product Development and Engineering Technologies, which focused on progressing the implementation of small-scale tools and models to drive the pipeline. She holds a B.S. and Ph.D. in Chemical Engineering from the University of Arizona and the University of Texas at Austin, respectively.